Every open market buy and sale of Rapport Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $22M bought and $46.7M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when RAPP insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an RAPP officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
RAPP cluster buys
All RAPP cluster buys →- 7 insiders bought $22MTrades Oct 21, 2026 to Oct 28, 2026 · public Oct 22, 2026
A cluster buy is two or more insiders buying on the open market within 30 days of each other.
Every RAPP insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | James HealyDirector | Buy | 969,480 | $21.00 | $20.4M | 25,267 | Oct 30Form 4 |
| Oct 23, 2026 | Ramiro SanchezDirector | Buy | 3,600 | $27.35 | $98K | 3,600 | Oct 23Form 4 |
| Oct 22, 2026 | John MaraganoreDirector | Buy | 9,411 | $26.45 | $249K | 9,411 | Oct 22Form 4 |
| Oct 22, 2026 | Steven M PaulDirector | Buy | 35,714 | $27.28 | $974K | 77,380 | Oct 22Form 4 |
| Oct 22, 2026 | Wendy B. YoungDirector | Buy | 3,789 | $26.39 | $100K | 13,289 | Oct 22Form 4 |
| Oct 22, 2026 | Paul M SilvaDirector | Buy | 3,680 | $27.07 | $100K | 3,680 | Oct 22Form 4 |
| Oct 21, 2026 | Abraham CeesayCEO | Sale plan | 2,210 | $29.16 | $64K | 450,035 | Oct 23Form 4 |
| Oct 21, 2026 | Troy A. IgnelziCFO | Buy | 5,500 | $26.10 | $144K | 15,500 | Oct 21Form 4 |
| Oct 7, 2026 | Abraham CeesayCEO | Sale plan | 4,522 | $31.68 | $143K | 452,245 | Oct 8Form 4 |
| Sep 30, 2026 | Cheryl GaultCOO | Sale plan | 10,000 | $33.19 | $332K | 139,914 | Oct 1Form 4 |
| Sep 23, 2026 | Abraham CeesayCEO | Sale plan | 2,210 | $39.17 | $87K | 456,767 | Sep 24Form 4 |
| Sep 8, 2026 | Abraham CeesayCEO | Sale plan | 8,210 | $45.61 | $374K | 458,977 | Sep 9Form 4 |
| Aug 25, 2026 | Krishnaswamy YeleswaramChief Development Officer | Sale plan | 50,160 | $50.47 | $2.5M | 195,862 | Aug 26Form 4 |
| Aug 25, 2026 | Abraham CeesayCEO | Sale plan | 18,921 | $49.57 | $938K | 467,187 | Aug 26Form 4 |
| Aug 19, 2026 | Krishnaswamy YeleswaramChief Development Officer | Sale plan | 404 | $49.90 | $20K | 246,022 | Aug 20Form 4 |
RAPP insider trading FAQ
Are RAPP insiders buying or selling?
Insiders are net sellers over the last 12 months. 7 insiders bought $22M of RAPP on the open market in 7 trades, and 5 sold $46.7M in 32 trades, 99% of that under pre-arranged trading plans.
When did an RAPP insider last buy shares?
James Healy (Director) bought 969,480 shares for $20.4M on Oct 28, 2026, reported on Oct 30, 2026.
When did an RAPP insider last sell shares?
Abraham Ceesay (CEO) sold 2,210 shares for $64K on Oct 21, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
